Heart shield? antioxidant supplement tested to prevent chemo damage in breast cancer
NCT ID NCT06703593
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 27 times
Summary
This study tested whether alpha lipoic acid, an antioxidant supplement, could prevent heart damage caused by the chemotherapy drug doxorubicin in 80 women with breast cancer. Participants received either the supplement or a placebo alongside their first round of chemo. The researchers measured changes in heart function and blood markers of heart stress to see if the supplement offered protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER FEMALE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The British University in Egypt
Cairo, El-Sherouk City, 11837, Egypt
Conditions
Explore the condition pages connected to this study.